Empagliflozin in chronic kidney disease: nephroprotection is independent of albuminuria, primary kidney disease, and baseline eGFR

MeSH terms

• Albuminuria / drug therapy
• Benzhydryl Compounds / therapeutic use
• Diabetes Mellitus, Type 2* / complications
• Diabetes Mellitus, Type 2* / drug therapy
• Glomerular Filtration Rate
• Humans
• Kidney
• Renal Insufficiency, Chronic* / complications
• Renal Insufficiency, Chronic* / drug therapy